A high-throughput drug combination screen identifies an anti-glioma synergism between TH588 and PI3K inhibitors.

Zhen ChenChao ChenTingting ZhouChao DuanQianqian WangXiaohui ZhouXia ZhangFangrong WuYunfen HuaFan Lin

Published in: Cancer cell international (2020)

The screening method developed in this study demonstrated its usefulness in the rapid identification of synergistic drug combinations of PI3K inhibitors and targeted agents.

Keyphrases

high throughput
cancer therapy
single cell
genome wide
adverse drug
drug induced
emergency department
drug delivery